Soft Tissue Regeneration announced that it has completed enrollment for a clinical trial of its L-C Ligament, a bioresorbable scaffold for soft tissue regeneration of the anterior cruciate ligament of the knee.
The clinical trial is a prospective, multicenter, non-randomized trial to evaluate the safety profile of the scaffold in 15 men and women with acute ACL injuries. It will be conducted in The Netherlands, in Europe.
Soft Tissue Regeneration is a medical device company whose aim is to apply its patented proprietary technology comprised of PLLA — a biodegradable polymer — in orthopedic implant devices for regeneration and augmentation of soft tissue.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws